Annexon to participate in September investor conferences
Annexon, Inc. said Douglas Love, Esq. will participate in upcoming September investor conferences.
BRISBANE, Calif., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc.
NASDAQ:ANNX, a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq…